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The fungal cell wall contains glycoproteins that interact with the host immune system.
In the prominent pathogenic yeast Candida albicans, Pmr1 acts as a Golgi-resident
ion pump that provides cofactors to mannosyltransferases, regulating the synthesis of
mannans attached to glycoproteins. To gain insight into a putative conservation of such
a crucial process within opportunistic yeasts, we were particularly interested in studying
the role of the PMR1 homolog in a low-virulent species that rarely causes candidiasis,
Candida guilliermondii. We disrupted C. guilliermondii PMR1 and found that loss of
Pmr1 affected cell growth and morphology, biofilm formation, susceptibility to cell wall
perturbing agents, mannan levels, and the wall composition and organization. Despite
the significant increment in the amount of β1,3-glucan exposed at the wall surface, this
positively influenced only the ability of the mutant to stimulate IL-10 production by human
monocytes, suggesting that recognition of both mannan and β1,3-glucan, is required to
stimulate strong levels of pro-inflammatory cytokines. Accordingly, our results indicate
C. guilliermondii sensing by monocytes was critically dependent on the recognition of
N-linked mannans and β1,3-glucan, as reported in other Candida species. In addition,
chemical remotion of cell wall O-linked mannans was found to positively influence the
recognition of C. guilliermondii by human monocytes, suggesting that O-linked mannans
mask other cell wall components from immune cells. This observation contrasts with that
reported in C. albicans. Finally, mice infected with C. guilliermondii pmr11 null mutant
cells had significantly lower fungal burdens compared to animals challenged with the
parental strain. Accordingly, the null mutant showed inability to kill larvae in the Galleria
mellonella infection model. This study thus demonstrates that mannans are relevant for
the C. guilliermondii-host interaction, with an atypical role for O-linked mannans.
Keywords: cell wall, mannosylation pathway, Candida guilliermondii, host-fungus interplay, virulence, protein
glycosylation
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INTRODUCTION
Several members of the Candida genus cause both superficial and
systemic candidiasis, the latter resulting in significant morbidity
and mortality, especially in immunosuppressed patients (Brown
et al., 2012). Indeed, invasive candidiasis is ranked as the
second most lethal infection caused by opportunistic fungal
pathogens, and Candida albicans remains the most frequent
species isolated from affected patients (Brown et al., 2012).
However, other species of this genus can cause life-threatening
infections and are regarded as emerging pathogens. Candida
guilliermondii is an opportunistic yeast that accounts for 1–3% of
all candidemia cases, most frequently in patients with oncological
diseases (Girmenia et al., 2006; Pfaller et al., 2006; Savini et al.,
2011). Although this organism is medically relevant, it is still
considered a low-virulence species (Savini et al., 2011); therefore,
its study can provide insights into differences in pathogenicity
mechanisms, virulence and interaction with host cells from that
of other more virulent species, such as C. albicans.
Host immune sensing of fungal antigens is a key step
in the development of a protective anti-fungal response, and
recognition of fungal cell wall constituents initiates this process
(Netea et al., 2008). Thus far, the C. albicans cell wall is the most
well studied fungal structure, and models about its composition,
structure, organization and relevance during the interaction
with host cells are available (Klis et al., 2001; Díaz-Jiménez
et al., 2012; Gow and Hube, 2012; Gow et al., 2012; Netea
et al., 2015). The C. albicans cell wall is composed of structural
polysaccharides (chitin, β1,3- and β1,6-glucans) that surround
the plasma membrane (inner wall layer) and an outer layer
composed of N- and O-linked mannoproteins (Klis et al., 2001).
All these components are recognized as pathogen-associated
molecular patterns and are capable of stimulating both cytokine
production and phagocytosis by innate immune cells (Martínez-
Álvarez et al., 2014). Several receptors on the surface of immune
cells involved in the sensing of C. albicans cell wall components
have been identified. For example, the N-linked mannans are
recognized bymannose receptor, DC-SIGN,Mincle, dectin-2 and
dectin-3 (Netea et al., 2006; Cambi et al., 2008; Wells et al., 2008;
Saijo et al., 2010; Zhu et al., 2013), while O-linked mannans
are sensed via TLR4 (Netea et al., 2006). β1,3-Glucan stimulates
signaling pathways in the immune cells when interacting with
dectin-1 and TLR2 (Brown and Gordon, 2001; Netea et al.,
2006), and chitin has been recently reported to be sensed by
the mannose receptor and the intracellular molecules TLR9 and
NOD2 (Wagener et al., 2014). Despite this significant advance in
understanding the C. albicans-immune system interactions, little
is known about C. guilliermondii immune sensing. Thus far, it
has been established that C. guilliermondii is a moderate stimulus
for production of granulocyte-macrophage colony-stimulating
factor and the complement components C3 and factor B by
human monocytes (Høgåsen et al., 1995). Accordingly, C.
guilliermondii displayed a limited capacity to stimulate tumor
necrosis factor α (TNFα) when co-incubated with peritoneal
macrophages (Aybay and Imir, 1996). However, it is readily
phagocytosed by murine polymorphonuclear cells, bone marrow
cells, peritoneal macrophages and spleen cells, when compared
to the phagocytic index of C. albicans cells (Vecchiarelli et al.,
1985).
Similar to the studies dealing with the immune sensing, the
C. guilliermondii cell wall structure and composition have been
poorly studied, but its cell wall is nevertheless assumed to be
similar to the one described in C. albicans. C. guilliermondii cell
wall contains chitin, which increases in amount in response to
exposure to sub-lethal concentrations of caspofungin (Walker
et al., 2013). Furthermore, structural analysis of C. guilliermondii
cell wall mannans indicated the presence of α1,2-, α1,3- and
β1,2-mannose units, suggesting a similar organization to the C.
albicansmannans (Okawa et al., 2006).
Mannan relevance for Candida spp. cell wall integrity,
virulence, and sensing by innate immune cells has been mainly
assessed using mutant cells lacking specific enzymes with key
roles in the assembly of either N- or O-linked mannans (Bates
et al., 2005, 2006, 2013;Munro et al., 2005; Prill et al., 2005;Mora-
Montes et al., 2007, 2010; Hall et al., 2013;West et al., 2013; Pérez-
García et al., 2016). Pmr1 is a Golgi-resident P-type ATPase ion
pump that provides the cofactor Mn2+ to mannosyltransferases
involved in both N-linked and O-linked glycosylation (Bates
et al., 2005). A previously generated C. albicans pmr11 null
mutant displayed a strong defect in the cell wall composition and
elaboration of bothN-linked andO-linked mannans (Bates et al.,
2005); and thus, produced a poor cytokine response in human
peripheral-bloodmononuclear cells (PBMCs) and dendritic cells,
and its phagocytosis by macrophages was significantly affected
(Netea et al., 2006; Cambi et al., 2008; McKenzie et al., 2010);
these findings underscore the relevance of both N- and O-
linkedmannans for a properC. albicans-immune cell interaction.
Furthermore, functional differences arising from β-elimination
by trimming of O-linked mannans or removal of N-linked
mannans upon treatment with endoglycosidase H (endo H) have
also added to our understanding of the physiological role of
mannans in the biology of Candida spp. (Hamada et al., 1981;
Hazen and Glee, 1994; Mormeneo et al., 1994; Goins and Cutler,
2000; Spreghini et al., 2003; Pérez-García et al., 2016).
Here, we disrupted C. guilliermondii PMR1 (CgPMR1) and
found that the loss of proper protein mannosylation affected
cell growth and morphology, biofilm formation, cell wall
composition and organization, and interaction with human
PBMCs and the cell line J774 of murine macrophages. In
addition, virulence was affected in the model of systemic
candidiasis in both the invertebrate Galleria mellonella and mice.
Interestingly, we also found that C. guilliermondii and C. albicans
O-linked mannans are similar in composition, but the former
mask other cell wall components from interaction with human
PBMCs, preventing a significant increase in cytokine production
compared to that generated by the pmr11 null mutant.
RESULTS
Identification of C. guilliermondii PMR1
and Construction of a Null Mutant Strain
The CgPMR1 sequence was identified following a standard
protein BLAST analysis at the NCBI website (http://www.ncbi.
Frontiers in Microbiology | www.frontiersin.org 2 December 2016 | Volume 7 | Article 1951
Navarro-Arias et al. Disruption of Candida guilliermondii PMR1
nlm.nih.gov/), using the protein sequence of C. albicans Pmr1
(GenBank accession code XP_720380) as query. The best hit was
the hypothetical protein PGUG_00945 (GenBank accession code
EDK36847), which is encoded by the locus CH408155 (GenBank
accession code CH408155, region: 1663175..1665946). This open
reading frame (ORF) spans 2772 bp and is predicted to encode
a polypeptide of 923 amino acids, with 76 and 87% identity
and similarity to C. albicans Pmr1, respectively. The putative
protein is predicted to bear eight transmembrane domains and
the canonical motif 353DKTGTLT, which contains the aspartic
acid residue involved in the phosphorylation of P-type ATPases
(Lutsenko and Kaplan, 1995; Bates et al., 2005). Furthermore, this
ORF is unlikely to be the ortholog of other membrane-bound
ATPases, such as ENA2, PMC1, or PMA1, as the identity and
similarity to those proteins was relatively low (30.8 and 48.3%,
28.3 and 46.8%, 27.1 and 47.8%, respectively).
To demonstrate that CgPMR1 is the functional ortholog of the
CaPMR1, we complemented a C. albicans pmr11 null mutant
(Bates et al., 2005) with C. guilliermondii PMR1 under the
control of its native promoter. The phenotypical analysis of the
mutant strain indicated that C. guilliermondii PMR1 restored the
cell wall composition of the C. albicans pmr11 null mutant to
levels similar to those found in the wild-type (WT) control cells
(Figure 1A). Furthermore, the cell wall phosphomannan content
was restored upon transformation with the C. guilliermondii gene
(Figure 1B). Therefore, C. guilliermondii PMR1 is the functional
ortholog of C. albicans PMR1.
The CgPMR1 disruption was performed in the KU141F1
recipient strain (genotype ura5, ku70) using the URA5 blaster
strategy (Foureau et al., 2013b). Replacement of the PMR1
ORF with the disruption cassette was confirmed by PCR
(Figures 2A,B). To generate a re-integrant control strain, the
C. guilliermondii pmr11 null mutant was subjected to recycling
of the URA5 blaster cassette, yielding a Ura− strain (pmr11
FOAR, Figures 2A,B), and transformed either with pG-URA5-
PMR1-YFP or pG-URA5-YFP-PMR1. These constructions allow
the expression of chimeric proteins Pmr1-YFP or YFP-Pmr1.
When observed by epifluorescence microscopy, both series of
transformed cells exhibited a network-shaped fluorescent signal,
suggesting the targeting of the Pmr1-YFP and YFP-Pmr1 fusion
proteins in the native organelle where Pmr1 was previously
reported in other yeast species (Huh et al., 2003), i.e., the Golgi
complex (Figure 2C). A representative C. guilliermondii pmr11
null mutant strain as well as a representative pmr11 FOAR +
pG-URA5-PMR1-YFP re-integrant strain (abbreviated pmr11+
PMR1) were selected for further phenotype analysis.
Colony, Cell Morphology and Ability to
Form Biofilms of the C. guilliermondii
pmr11 Null Mutant
The null mutant tended to grow as small colonies with irregular
border and surface. In addition, the mutant was found to
spontaneously form pseudohyphae and cell aggregates when
cultured in liquid media (Figure 2D). The cell aggregates were
dispersed upon addition of 2 units/mL chitinase (Bates et al.,
2006; Pérez-García et al., 2016), suggesting defects in cell
separation associated to alterations of the cell wall (data not
shown). The growth rate of the C. guilliermondii pmr11 null
mutant was significantly reduced, with doubling times of 3.64
± 0.35 h, when compared with the control strains: 2.64 ±
0.17 h, and 2.85 ± 0.21 h for the parental (KU141) and re-
integrant (pmr11 + PMR1) strains, respectively (P < 0.05).
Experiments conducted in the presence of 2 units/mL chitinase
showed similar results (data not shown). The pmr11 null
mutant, but not the parental or re-integrant control cells failed
to grow in SC medium supplemented with 15 mM EGTA,
suggesting a strong defect in calcium mobilization (data not
shown). We next tested the ability of the pmr11 null mutant
to form biofilms on a polystyrene surface. The pmr11 null
mutant displayed a 41.7± 13.8% reduction in the ability to form
biofilms, which was statistically significant when compared to
the parental and re-integrant control strains (100 ± 14.1% and
97.8 ± 10.6%, respectively; P < 0.05) Therefore, loss of PMR1
affects C. guilliermondii growth, morphology, and ability to form
biofilms.
The Cell Wall Composition, Mannosylation,
Organization and Susceptibility to Cell Wall
Perturbing Agents Is Affected in the pmr11
Null Mutant
To decipher a putative role of PMR1 on C. guilliermondii
cell wall composition, yeast cell walls were isolated, acid
hydrolyzed and analyzed by High-Performance Anion-Exchange
Chromatography with Pulsed Amperometric Detection
(HPAEC-PAD) as detailed in the Experimental procedures.
Importantly, the parental strain (KU141) used for generating
the pmr11 null mutant also bears a mutation in KU70 (Foureau
et al., 2013b). Therefore, to demonstrate the lack of effect of
the KU70 mutation on the studied phenotypes, we included
in the analyses the ATCC 6260 reference strain (WT) as an
additional control. The cell wall of control strains was similar in
carbohydrate and protein contents, as well as in wall porosity to
the polycation DEAE-dextran, an indirect reporter of mannan
arrangement (Cheng et al., 2011; Pérez-García et al., 2016).
The pmr11 null mutant displayed significant changes in wall
composition, with a 5.8-fold and 1.8-fold increment in chitin
and glucan levels, respectively (Table 1). These modifications
were accompanied by a 13-fold reduction in mannan content,
whereas phosphomannan was basically absent from the null
mutant cell wall (Table 1). No significant differences in the
pmr11 cell wall protein levels were found, but the cell wall
porosity to DEAE-dextran was significantly reduced (Table 1).
To confirm the defect in the cell wall mannan content, we
removed either N-linked or O-linked mannans from the cell
wall using endo H treatment or β-elimination, respectively, and
quantified the amount of mannan released. The control strains
did not display any significant difference in the content of both
kinds of mannans, having about 65 and 35% of the mannan
content released upon endo H treatment (N-linked mannans)
and β-elimination (O-linked mannans), respectively (Figure 3).
As expected, the content of both mannans in the pmr11 null
mutant was significantly reduced, with a reduction of 97 and 71%
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FIGURE 1 | CgPMR1 is the functional ortholog of CaPMR1. CgPMR1 was expressed in the C. albicans pmr11 null mutant, as described in Experimental
procedures, and the cell wall was isolated and analyzed by High-Performance Anion-Exchange Chromatography with Pulsed Amperometric Detection to assess the
carbohydrate content (A). In addition, the ability of cells to bind Alcian blue was analyzed (B). *P < 0.05. Strains used are: NGY152 (WT), Capmr11 (NGY355),
Capmr11 + CgPMR1 (HMY186).
FIGURE 2 | Generation of the C. guilliermondii mutants used in this study and colony and cell morphology. (A) Schematic representation of the wild type
and disrupted PMR1 loci. The PMR1 was disrupted in the strain KU141F1 using the URA5 blaster system. (B) Generation of the null mutant was confirmed by PCR
reactions using the primer pair PMR11 5′-CTGAGAGGATCCATGACAGAGAACCCGTTCGATGTG-3′ and PMR12 5′-CTGAGAACTAGTTACGCTGTAGCTGACTCCAT
TCAT-3′ that amplifies the whole PMR1 locus. All the generated amplicons displayed the expected sizes, as indicated in (A) of the figure. (C) Subcellular localization of
YFP alone, Pmr1-YFP and YFP-Pmr1 fusion proteins in the pmr11 strain. Scale bar = 2 µm. (D) Colony and cell morphology of C. guilliermondii strains. Cells were
grown on SC medium at 30◦C for 36 h, scale bar = 1 mm. Alternatively, strains were cultured in SC broth at 30◦C for 18 h; scale bar = 10 µm. The strains used are:
KU141 (Parental), HMY134 (pmr11) and HMY138 (pmr11 + PMR1).
in the levels of N-linked and O-linked mannans, respectively
(Figure 3).
Furthermore, we assessed whether loss of PMR1 affected the
organization of structural polysaccharides within the cell wall.
For this purpose, we used a fluorescein isothiocyanate-wheat
germ agglutinin conjugate (WGA-FITC) and an IgG Fc-Dectin-
1 chimera, which are known to bind chitin and β1,3-glucan,
respectively (Graham et al., 2006; Mora-Montes et al., 2011;
Marakalala et al., 2013; Estrada-Mata et al., 2015), and analyzed
their abilities to bind these polysaccharides. Results shown in
Figure 4, Figures 1S, 2S indicate that live ATCC 6260, parental
(KU141), and re-integrant control strains were minimally labeled
by either WGA-FITC or IgG Fc-Dectin-1 chimera, indicating a
small proportion of chitin or β1,3-glucan exposed at the surface
of the cell wall. However, the live pmr11 null mutant was
significantly bound by both lectins (Figure 4, Figures 1S, 2S). The
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TABLE 1 | Cell wall analysis of Cgpmr11 null mutant and control strains.
Strain Cell wall abundance Phosphomannan content (µg)a Porosity (%)b Protein (µg)c
Chitin (%) Mannan (%) Glucan (%)
ATCC 6260 1.8±1.0 50.8± 0.7 47.4±2.5 121.9±12.4 61.4±6.5 144.2±24.1
KU141 (Parental) 1.9±0.6 49.2± 2.6 48.9±2.2 119.5±12.8 59.7±3.6 139.6±26.5
HMY134 (pmr11) 9.3±1.4* 3.9± 2.6* 86.7±4.8* 0.17±15.0* 37.5±3.1* 151.1±20.8
HMY138 (pmr11 + PMR1) 1.2±1.0 53.1± 2.2 45.7±3.1 115.6±10.7 63.0±6.1 141.8±19.1
KU141 (Parental)d 2.3±0.6 32.5± 1.9† 65.2±1.1† ND ND ND
HMY134 (pmr11)d 8.7±1.4* 1.1± 1.0 90.2±0.9 ND ND ND
HMY138 (pmr11 + PMR1)d 1.6±1.0 34.5± 0.9† 63.9±2.2† ND ND ND
KU141 (Parental)e 2.0±1.7 17.8± 2.4† 80.2±3.3† ND ND ND
HMY134 (pmr11)e 10.3±1.1 0.2± 0.4† 89.5±2.6 ND ND ND
HMY138 (pmr11 + PMR1)e 2.0±1.5 18.6± 1.8† 79.4±2.3† ND ND ND
aµg of Alcian Blue bound/OD600 = 1.
bRelative to DEAE-Dextran.
cµg of protein/mg of cell wall.
dUpon β-elimination.
eUpon treatment with endoglycosidase H.
*P < 0.05.
†
P < 0.05, when compared to untreated cells.
ND, Not determined.
FIGURE 3 | The C. guilliermondii pmr11 null mutant shows reduced
levels of both N-linked and O-linked mannans at the cell wall. The C.
guilliermondii strains ATCC 6260, KU141 (Parental), HMY134 (pmr11) and
HMY138 (pmr11 + PMR1) were treated with endoglycosidase H or
β-eliminated to remove N-linked mannans or O-linked mannans, respectively.
The released material was concentrated and sugar content was quantified as
described in Experimental procedures. Data are means ± SD of three
independent experiments performed in duplicates. *P < 0.05.
increased labeling was not associated to the morphology change
in the pmr11 null mutant, as pseudohyphae and yeast cells from
the ATCC 6260 and parental (KU141) strains showed a similar
ability to bind either WGA-FITC or IgG Fc-Dectin-1 (data not
shown). It has been reported that heat-inactivatedC. albicans and
Candida parapsilosis cells expose β1,3-glucan and chitin at the cell
wall surface (Gow et al., 2007; Mora-Montes et al., 2011; Estrada-
Mata et al., 2015; Pérez-García et al., 2016); hence, as anticipated,
there was an increased binding by both lectins in heat-killed
(HK) control C. guilliermondii cells (Figure 4, Figures 1S, 2S).
Interestingly, there was not an increment in the labeling by both
lectins in the HK pmr11 null mutant when compared to live null
mutant cells, suggesting that most of chitin and β1,3-glucan is
already exposed at the cell surface (Figure 4, Figures 1S, 2S).
FIGURE 4 | The cell-wall structural polysaccharides, chitin and
β1,3-glucan, are significantly exposed at the cell surface of the
C. guilliermondii pmr11 null mutant. Live or heat-killed (HK) yeast cells
were incubated with either fluorescein isothiocyanate-wheat germ agglutinin
conjugate (closed bars, labels chitin) or IgG Fc-Dectin-1 chimera (open bars,
labels β1,3-glucan) as described in the Experimental procedures, inspected
under fluorescence microscopy, and the fluorescence associated to 100
individual cells recorded. The strains used are: ATCC 6260, KU141 (Parental),
HMY134 (pmr11) and HMY138 (pmr11 + PMR1) *P < 0.05, when compared
with live and HK cells from KU141, HMY134, and HMY138 strains.
Next, we assessed the effect of cell wall perturbing agents
and compounds associated with glycosylation defects on the
growth of C. guilliermondii strains. The pmr11 null mutant
showed increased susceptibility to Calcofluor white, Congo
red, tunicamycin and hygromycin B (P < 0.01 in all cases;
Figure 5). In addition, null mutant cells displayed an increased
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FIGURE 5 | C. guilliermondii pmr11 null mutant shows increased susceptibility to cell wall perturbing agents. The C. guilliermondii strains ATCC 6260,
KU141 (Parental), HMY134 (pmr11), and HMY138 (pmr11 + PMR1) were incubated with different concentrations of either Calcofluor White, Congo Red,
Tunicamycin, or Hygromycin B, and growth was determined after incubation for 24 h at 30◦C. Growth data were normalized as percentage of those generated with
the same strain without treatment. For data normalization, growth results are shown as percentage of those obtained with the same strain growing in the absence of
any perturbing agent. Data are means ± SD of three independent experiments performed in duplicates. For all the agents tested, the null mutant sensitivity was
significantly different to that of the control strains (P < 0.01 when compared by two-way ANOVA).
sensitivity to SDS, which affects the plasma membrane (Bates
et al., 2006; Mora-Montes et al., 2007; Pérez-García et al., 2016)
(data not shown). For all of the perturbing agents, the control
strains were largely resistant, and no significant difference were
found among them (Figure 5). Interestingly, the pmr11 null
mutant displayed a reduced susceptibility toward fluconazole,
but not to nystatin (not shown), with a fluconazole minimal
inhibitory concentration (MIC) of 18.3 ± 3.8 µg/mL after 24 h
incubation at 30◦C (MIC for the ATCC 6260, parental (KU141)
and re-integrant control strains are 7.1 ± 3.0 µg/mL, 8.5 ±
4.8 µg/mL, and 9.1 ± 3.3 µg/mL, respectively; P = 0.03).
Therefore, the pmr11 null mutant has significant defects in cell
wall composition, organization and fitness.
Loss of C. guilliermondii Protein
Mannosylation Affects Cytokine
Production by Human PBMCs
We next assessed the relevance of protein mannosylation
during the host-fungus interaction, analyzing the ability of
C. guilliermondii to stimulate cytokine production by human
PBMCs. Live C. guilliermondii cells from control strains
stimulated low and similar TNFα, IL-1β, IL-6, and IL-
10 levels (Figure 6); however, when heat inactivated, both
strains stimulated significantly higher levels of these cytokines
(Figure 6). Live pmr11 null mutant induced similar levels of
TNFα, IL-1β, and IL-6, when compared to live control cells, but
these levels showed no increment upon heat killing (Figure 6).
Importantly, the re-integrant control strain stimulated cytokine
production at similar levels to those generated with the other
control strains (Figure 6). For IL-10 production, the pmr11
null mutant stimulated similar and intermediate levels of this
cytokine in both live and HK forms; which were significantly
different when compared with those induced with the control
cells: higher in the case of live cells and lower when HK cells
were used (Figure 6). In accord with these observations, cells
with mannoses shaved by endo H and β-elimination, with low
levels of mannan on the cell wall (Figure 3) produced cytokine
levels similar to that of the pmr11 null mutant, stressing the
relevance of both N-linked and O-linked mannans for maximal
stimulation of TNFα, IL-6, and IL-1β (Figure 6). Furthermore,
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FIGURE 6 | The loss of proper cell wall mannosylation affects the ability of C. guilliermondii to stimulate cytokine production by human PBMCs. Fungal
cells were co-incubated with human PBMCs, the supernatant saved and used to quantify pro- and anti-inflammatory cytokines. Results (means ± SD) were obtained
using samples from six donors, each assayed in duplicate wells. The strains used are: ATCC 6260, KU141 (Parental), HMY134 (pmr11) and HMY138 (pmr11 +
PMR1) *P < 0.05, when compared with live cells;
‡
P < 0.05, when compared with cells subjected to the same treatment; ||P < 0.05, when compared with untreated
yeast cells.
these results also confirmed that loss of both types of mannans
disrupts the proper IL-10 stimulation (Figure 6). The null mutant
cells treated with endo H and β-eliminated displayed the same
ability to stimulate cytokine production than the untreated,
null mutant cells (Figure 6). Therefore, N-linked and O-linked
mannosylation in C. guilliermondii are directly linked to the
stimulation of cytokines by human PBMCs.
The O-Linked Mannans Negatively Affect
the Recognition of C. guilliermondii by
Human PBMCs
Since the double treated cells with endo H and β-elimination
displayed a similar ability to stimulate cytokine production as
the pmr11 null mutant strain, and β-elimination has been
recently used to explore the role of O-linked mannans in
the C. parapsilosis-host interaction (Estrada-Mata et al., 2015;
Pérez-García et al., 2016), we next examined the importance of
fungal O-linked mannans during the interaction between human
PBMCs and C. guilliermondii. Upon β-elimination, both parental
(KU141) and re-integrant control strains tended to lose about
35% of cell wall mannan. This modification was accompanied
with a significant increment in the content of β-glucan (Table 1).
Conversely, the pmr11 null mutant only showed a higher
content in β-glucan levels (Table 1). Live ATCC 6260, parental
(KU141), and re-integrant control strains stimulated higher
TNF-α, IL-6, IL-1β, and IL-10 levels than those challenged with
untreated cells, and these cytokine levels were as high as those
measured with untreated-HK cells (Figure 6). β-Elimination did
not affect the cytokine levels induced by HK control or mutant
cells, nor the levels measured after challenge with the pmr11
null mutant (Figure 6). Therefore, these data suggest that O-
linked mannans play a minor role in the stimulation of the
analyzed cytokines. This indicates that these oligosaccharides
mask otherC. guilliermondii cell wall components responsible for
the stimulation of a strong cytokine production.
Analysis of the O-linked mannans collected after
β-elimination by fluorophore-assisted carbohydrate
electrophoresis indicated the presence of glycans containing
from one to seven mannose units in samples from the parental
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(KU141) and re-integrant control strains (Figure 7). This
electrophoretic profile was similar to that observed for O-
linked mannans isolated from C. albicans (Figure 7). The
sample from the pmr11 null mutant showed only one single
band migrating at the same level as a single glucose residue
(Figure 7).
The N-Linked Mannans Are Key
Components to Stimulate Cytokine
Production by Human PBMCs
Following a similar strategy to study the contribution of O-
linked mannans during C. guilliermondii-PBMC interaction, we
treated the fungal cells with endo H to trim N-liked mannans
from the cell wall (Figure 3) and used these cells to analyze the
cell wall composition and to stimulate cytokine production by
human PBMCs. The cell wall of the parental and re-integrant
control strains showed a significant reduction in the mannan
content and increment in β-glucan levels after trimming of N-
linked mannans. However, the pmr11 null mutant cell wall
barely showed mannan levels upon deglycosylation with endo H
(Table 1). Results in Figure 6 clearly indicate that the removal
of N-linked mannan from the cell wall of live C. guilliermondii
ATCC 6260 cells did not change levels of TNF-α, IL-6, and
IL-1 β compared to PBMC exposure to untreated yeast cells.
A similar result occurred with the other control strains. In
the case of HK cells, the three control strains, ATCC 6260,
parental (KU141) and re-integrant, stimulated lower levels of
pro-inflammatory cytokines, comparable to those stimulated
with live cells (Figure 6). The treatment with endo H did
not affect the ability of the pmr11 null mutant to stimulate
cytokine production (Figure 6). The lack of N-linked mannans
did not affect the levels of IL-10 induced by either the live
or HK pmr11 null mutant; but live and HK control strains
stimulated similar levels of IL-10 as the null mutant, which were
significantly different from those stimulated by untreated cells
(Figure 6). Taken together, these data reveal thatC. guilliermondii
N-linked mannans are key cell wall components for inducing the
production of cytokines by human PBMCs.
Dectin-1 Is Required for Cytokine
Production Stimulated by C. guilliermondii
Since mannan sensing is required for a strong cytokine
production in response to C. guilliermondii, we next analyzed
the contribution of β1,3-glucan recognition during the
FIGURE 7 | Fluorophore-assisted carbohydrate electrophoresis of O-linked mannans. Upon β-elimination, O-linked mannans were derivatized with
8-aminonaphthalene-1,3,6-trisulfonic acid and sodium cyanoborohydride and separated in a 35% (w/v) polyacrylamide gel under non-denaturing conditions. The
image is representative of three independent experiments. The strains used are NGY152 (WT) KU141 (Parental), HMY134 (pmr11), and HMY138 (pmr11 + PMR1).
The molecular marker used was a ladder of maltooligosaccharides from one (G1) to seven (G7) glucose units.
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C. guilliermondii-human PBMCs interaction. Upon pre-
incubation of the human innate immune cells with laminarin,
the production of TNFα, IL-6, IL-1β, and IL-10 stimulated by
live parental (KU141) cells did not significantly change, when
compared with the system in absence of laminarin (Figure 8).
However, laminarin blocked the cytokine production when cells
were challenged with HK parental, live β-eliminated parental or
HK β-eliminated parental cells (Figure 8). Similar results were
observed when the ATCC 6260 or the re-integrant control strains
were used (Figure 3S). No changes in the levels of TNFα, IL-6,
and IL-1β were observed in cells pre-treated with laminarin and
exposed to the pmr11 null mutant; however, IL-10 levels were
significantly reduced when cells were stimulated with either live
or HK mutant cells with or without β-elimination. Altogether,
these results clearly indicate that recognition of β1,3-glucan via
dectin-1 strongly influences the cytokine production in response
to C. guilliermondii.
Interaction of C. guilliermondii with Murine
Macrophages
We next assessed the cellular interactions of the C. guilliermondii
strains with murine macrophages. For this purpose, we used
a recently developed in vitro model, allowing monitoring of
multiple parameters for both cell types over time (Dementhon
et al., 2012). In the case of the control strains (parental and re-
integrant cells), about 90% of the macrophages survived after
24 h of infection (Figure 9, left panels, and Figure 4S). When
infected with the pmr11 null mutant, macrophages survival was
lower (about 70%). The proportion of macrophages engaged
in phagocytosis was lower when infected with the pmr11 null
mutant compared to the control strains (20% vs. ∼40% at T 1 h,
and 40% vs. 70% respectively at T 24 h, Figure 9, left panels,
and Figure 4S). Concerning the fungal biomass internalization
by the macrophages, Figure 9 clearly shows a lower uptake of the
pmr11 null mutant cells when compared to the control cells. At
T 24 h, about 80% of the controls cells were internalized; whereas
most of the pmr11 null mutant cells were outside macrophages.
Taken together, our data reveal that loss of PMR1 significantly
affects the interaction of C. guilliermondii cells with murine
macrophages.
C. guilliermondii PMR1 Is Required for
Virulence in Both Galleria mellonella and
the Mouse Model of Systemic Candidiasis
Finally, to establish the role of protein mannosylation in the
C. guilliermondii virulence, we assessed the capacity of this yeast
to cause disease in G. mellonella larva and mice. The parental
(KU141) and the re-integrant control strain killed all of the
G. mellonella larvae by the sixth day post-inoculation, whereas
all larvae infected with the pmr11 null mutant remained alive
during the observation period, which was prolonged to 12-day
post-inoculation (Figure 10). Furthermore, fungal burden was
significantly reduced in animals inoculated with the pmr11 null
mutant (1.5 × 108 ± 0.4 cfu/g, 5.8 × 108 ± 0.9 cfu/g, and
5.3 × 108 ± 1.1cfu/g, for the pmr11 null mutant, parental
(KU141), and the re-integrant control strain, respectively; P <
0.05 when compared the burden associated to the null mutant
with the control strains). We next used a non-lethal murine
experimental model of disseminated candidiasis as previously
reported (Ifrim et al., 2014; Pérez-García et al., 2016). At 2
days post-infection, BALB/c mice infected with the pmr11
null mutant had similar fungal burdens in the spleen, kidneys
and liver, as that measured in organs from mice infected with
the parental strain (Figure 11). Interestingly, the fungal burden
in the spleen and kidneys, but not in liver, was significantly
higher at this time interval in animals infected with the re-
integrant control strain (Figure 11). At 5-day post-infection,
pmr11 challenged-mice showed a significant reduction in the
fungal burdens in the spleen, kidneys and liver, compared to
animals infected with the parental yeast cells. Again, it was
interesting that, the group of animals infected with the re-
integrant control strain at 5 days-post infection displayed fungal
burdens that were similar to that measured in mice infected
with the null mutant strain (Figure 11). Therefore, these results
confirm that the loss of PMR1 significantly affects the virulence
of C. guilliermondii in vivo.
DISCUSSION
A thorough search in the literature and available databases
indicates that there are a limited number of disrupted genes
in C. guilliermondii, and most of them have been used as
markers to develop gene manipulation techniques (Millerioux
et al., 2011a,b; Foureau et al., 2013a,c; Papon et al., 2013). Our
work now presents the first C. guilliermondii null mutant with
defects in protein mannosylation, in the cell wall and interaction
with the host. The herein reported bioinformatics analysis, the
heterologous complementation in C. albicans and the inability
of the C. guilliermondii pmr11 null mutant to grow in presence
of EGTA strongly suggest that the ORF we have analyzed is the
functional ortholog of C. albicans PMR1. It is noteworthy that C.
guilliermondii PMR1 was controlled by its native promoter when
introduced into the C. albicans pmr11 null mutant, indicating
that the transcriptional machinery and the cis elements within
this promoter are similar between these two organisms, despite
their belonging to different subclades of the Candida clade
(Butler et al., 2009).
Using epifluorescence microscopy, we demonstrated that
C. guilliermondii Pmr1 tagging with the yellow fluorescent
protein did not affect the enzyme activity, as the phenotypes
associated with loss of PMR1 were restored in the re-integrant
control strain. Moreover, the fluorescent chimeric protein
displayed a compartmentalized intracellular pattern, which most
likely represents its distribution within the Golgi complex, as
previously reported in Saccharomyces cerevisiae Pmr1 (Huh
et al., 2003). This strategy did not affect protein localization
in S. cerevisiae, but its activity was not studied. As previously
mentioned, the parental strain used here is in fact a ku701
null mutant, and thus it is feasible to conceive that any of the
analyzed phenotypes can be associated to loss of KU70 instead
of disruption of PMR1. However, this is an unlikely scenario,
since the parental strain displayed similar phenotypic traits to the
Frontiers in Microbiology | www.frontiersin.org 9 December 2016 | Volume 7 | Article 1951
Navarro-Arias et al. Disruption of Candida guilliermondii PMR1
FIGURE 8 | Blocking of dectin-1 affects human PBMC cytokine induction in response to C. guilliermondii. Human PBMCs were pre-incubated with
laminarin for 1 h at 37◦C prior to co-culture with yeast cells. After 24 h incubation at 37◦C, the supernatants were saved and used to quantify cytokine levels. Results
(means ± SD) were obtained using samples from six donors, each assayed in duplicate wells. The strains used are: KU141 (Parental) and HMY134 (pmr11). *P <
0.05, when compared to the same yeast cell type without treatment.
ATCC 6260 reference strain, and we observed restoration of the
phenotype in the re-integrant control strain.
The C. guilliermondii pmr11 null mutant has characteristic
phenotypes associated with disruption of protein mannosylation
pathways: increased duplication rates, abnormal cell
morphology, decreased mannan content, and defects in the
cell wall composition, organization, porosity and fitness (Bates
et al., 2005, 2006, 2013; Munro et al., 2005; Mora-Montes
et al., 2007, 2010; Hall et al., 2013; Pérez-García et al., 2016).
Interestingly, we observed pseudohyphae formation in the
C. guilliermondii pmr11 null mutant, which has not been
shown for the C. albicans or S. cerevisiae pmr11 null mutants
(Antebi and Fink, 1992; Bates et al., 2005). The S. cerevisiae
pmr11 null mutant has an increase in intracellular calcium (Yu
et al., 2012), and high concentrations of this ion are required to
maintain tip enlargement of C. albicans hyphae (Brand et al.,
2007). So, it is possible that reorganization of calcium levels
within C. guilliermondii pmr11 null mutant affected the radial
growth of cells and a polarized growth was established instead.
Alternatively, since cells tended to form aggregates, it is possible
that the polarized growth is established in regions where the cell
surface is not in direct contact with other cells. Nevertheless, this
observation requires further analysis to properly understand this
phenotypic change.
The role of protein mannosylation in the ability of Candida
spp. to form biofilms has been poorly explored. Here we found
that disruption of this biosynthetic machinery negatively affected
the ability of C. guilliermondii to form biofilms, and these data
are in agreement with the adverse effect of tunicamycin (an
inhibitor of the early steps during N-linked mannan elaboration)
on C. albicans biofilms (Pierce et al., 2009). Since cell wall protein
diversity is likely to be affected in the C. guilliermondii pmr11
null mutant, it remains to be addressed whether changes in the
sugar moieties or the proteins are behind this observation.
C. albicans phosphomannosylation occurs in O-linked
mannans as well as in the N-linked mannan core and its outer
chain, and the loss of Pmr1 significantly affected the fungus’
ability to bind Alcian blue (Bates et al., 2005, 2006; Mora-
Montes et al., 2007). The C. guilliermondii pmr11 mutant was
unable to bind Alcian blue; thus, it is reasonable to suggest that
phosphomannan is absent from the N-linked mannan core, as
ability of the C. albicans pmr11 null mutant to bind this dye was
associated with this oligosaccharide moiety (Bates et al., 2005).
The reduced susceptibility to fluconazole associated with the loss
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FIGURE 9 | Multi-parametric analysis of murine macrophage interaction with C. guilliermondii cells over 24-h time course experiments. Macrophages
were infected with the parental (KU141), the pmr11 null mutant or the re-integrant (pmr11 + PMR1) strain as described in Materials and Methods. The diagram
shows the flow cytometer analysis of the infected macrophages on the left part. The macrophage survival is indicated by the horizontal bar. The white part of the bar
represents the percentage of non-phagocytosing macrophages; the gray part represents the percentage of macrophages engaged in phagocytosis. The right part of
the diagram shows the fluorometry analysis of the fungal population. The horizontal bar represents the multiplication of the yeast cells in the presence of
macrophages, expressed as a percentage of the initial biomass at T1h. The white part of the bar shows the percentage of extra-macrophagic yeasts, the gray part
shows the percentage of yeast cells internalized within the macrophages. Each condition was performed in quintuplet (flow cytometry experiments) or in triplicate
(fluorescence quenching experiments) per experiment. Each bar is the average of three independent experiments ± standard error. Unpaired T-test was used to
establish statistical significance. *P < 0.005.
of Pmr1 was unexpected, as S. cerevisiae pmr11 has been shown
to display hypersensitivity to this antifungal drug (Kapitzky et al.,
2010). Since we do not observe a similar result with nystatin, it
is unlikely that general cell wall rearrangements are responsible
for the resistance to fluconazole. Instead, the results suggest
that specific molecular components involved in the resistance to
fluconazole are dysregulated.
Cell wall mannans and β1,3-glucan play a pivotal role during
the C. albicans-innate immune system interaction (Martínez-
Álvarez et al., 2014), and truncation of C. albicans mannans
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FIGURE 10 | The C. guilliermondii pmr11 null mutant displays virulence
attenuation in the G. mellonella model. Inocula containing 2 × 107 yeast
cells were injected directly into the hemocoel of G. mellonella larvae and
survival was monitored daily. Experiments were performed three times, with a
total of 30 larvae per group (10 larvae for each experiment). Control,
PBS-injected group. The strains used are: KU141 (Parental), HMY134
(pmr11), and HMY138 (pmr11 + PMR1). No significant differences were
observed between the mortality associated to parental and pmr11 + PMR1
strains (P = 0.32). The pmr11 null mutant strain showed a significant
difference in the ability to kill larvae when compared to the parental or
re-integrant control strains (P < 0.05 in both cases).
reduces cytokine production by human PBMCs (Netea et al.,
2006; Mora-Montes et al., 2007, 2010). Similarly, HK C.
guilliermondii pmr11 null mutant or endo-H-treated and β-
eliminated WT cells induced lower levels of TNFα, IL-6,
and IL-1β production by PBMCs compared to untreated WT
cells, indicating that mannans indeed also have a significant
immunostimulatory effect. In contrast, truncated cell wall
mannans positively affected the stimulation of IL-10, and the
increased IL-10 production associated with live pmr11 null
mutant cells was blocked with the addition of laminarin,
indicating this was a dectin-1 dependent process. However,
the IL-10 levels stimulated by the HK null mutant cells were
lower than those associated with the control strains. A similar
observation was found in cells lacking proper N-linked mannan
elaboration in C. albicans (Mora-Montes et al., 2010), and
together, these data indicate that, as in C. albicans, stimulation
of IL-10 production in C. guilliermondii can be performed via
dectin-1, but both, mannan and β1,3-glucan recognition are
required for a strong IL-10 production (Netea et al., 2006;
Gow et al., 2007; Reid et al., 2009; Mora-Montes et al., 2010).
Treatment of C. guilliermondii with endo-H indicated that N-
linked mannans play a similar role in cytokine production by
human PBMCs as that reported in C. albicans, in which exposure
of β1,3-glucan by heat killing exposed key cell wall components
that induced high levels of pro-inflammatory cytokines (Netea
et al., 2006; Mora-Montes et al., 2007, 2010). Therefore, it is
likely that wall components are masking the β1,3-glucan layer
in C. guilliermondii, which effectively inhibit the triggering of
cytokine production via dectin-1, as reported in C. albicans
and C. parapsilosis (Wheeler and Fink, 2006; Gow et al., 2007;
Pérez-García et al., 2016).
It is interesting that, despite the pmr11 null mutant has
more β1,3-glucan exposed at the cell wall, this did not lead
to a higher stimulation of cytokines. Similar observations
FIGURE 11 | The C. guilliermondii pmr11 null mutant has decreased
virulence in the mouse model of systemic candidiasis.Wild-type BALB/c
mice were infected i.v. with 2 × 107 cells of either C. guilliermondii KU141
(Parental), HMY134 (pmr11), and HMY138 (pmr11 + PMR1), and the fungal
burdens in the spleen, kidneys and liver were determined at 2- or 5-days
post-infection. Data are expressed as colony forming units (CFU)/g tissue
(mean ± SEM). Results are pooled data from 2 separate experiments with 5
mice per group. *P < 0.05.
have been reported for C. albicans and C. parapsilosis null
mutants with defects in mannan elaboration and higher levels
of β1,3-glucan at the cell wall (Netea et al., 2006; Mora-
Montes et al., 2007, 2010; Pérez-García et al., 2016). These data
suggest that, although recognition of β1,3-glucan via dectin-
1 is important for the stimulation of cytokine production
in human PBMCs, this ligand-receptor interaction should be
part of a co-stimulation network where other receptors, along
with dectin-1, are triggering the production of significant
levels of cytokines. Indeed, it has been reported that dectin-1
collaborates with TLR-2, TLR-4, TLR-5, TLR-7, and TLR-9 in a
synergistic way to induce cytokine synthesis (Reid et al., 2009).
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Furthermore, it was recently reported that dectin-1 is important
during the sensing of C. albicans, but dispensable, as some C.
albicans strains with high content of cell wall chitin are not
recognized by this receptor (Marakalala et al., 2013). Therefore,
it is likely this co-stimulation network, involving dectin-1, also
occurs during the immune sensing of C. guilliermondii. The
C. albicans O-linked mannans account for a minor component
of the cell wall (Munro et al., 2005), and are dispensable for
cytokine stimulation by human PBMCs (Netea et al., 2006).
Here, we also observed that C. guilliermondii cells lacking N-
linked mannans, but displaying O-linked mannans in the cell
wall (endo-H treated cells), were unable to stimulate a robust
cytokine response, despite β1,3-glucan being exposed at the cell
surface. However, the chemical removal of O-linked mannans
(β-eliminated cells) from C. guilliermondii control cells resulted
in the induction of pro- and anti-inflammatory cytokines in
a manner similar to that observed with C. guilliermondii HK
cells. Our fluorophore-assisted carbohydrate electrophoresis of
C. guilliermondii O-linked mannans showed that the abundance
of glycans with different length is similar to that found in
C. albicans O-linked mannans, with structures composed from
one to seven residues. This technique has the sensitivity to
discriminate between oligosaccharides with the same size, but
composed of sugars bound with different glyosidic linkages
(Jackson, 1990). Thus, the intense bands, with lower migration
than the molecular marker are likely to be O-linked mannans
bearing a phosphomannan residue, which has been described in
C. albicans (Mora-Montes et al., 2007). These data also suggest
that theO-linkedmannans from C. guilliermondii should contain
α1,2-mannose units, as described in C. albicans (Munro et al.,
2005). The presence of O-linked mannans with one mannose
residue in the pmr11 null mutant was expected, as this is added
in the endoplasmic reticulum (Munro et al., 2005). Since cell
wallO-linkedmannans are more abundant (accounting for about
one third of the total mannan content) in C. guilliermondii
than in C. albicans, it is possible to suggest that, like N-linked
mannans, these oligosaccharides are masking inner cell wall
components of C. guilliermondii from recognition by immune
receptors. Along this line, a new and differential role forO-linked
mannans has been recently established during C. parapsilosis-
human PBMCs interaction (Estrada-Mata et al., 2015; Pérez-
García et al., 2016). It is noteworthy that β-elimination or endo-H
treatment, besides reducing mannan content, positively affected
the glucan levels, but not the chitin content. The cell wall integrity
pathway compensates defects in the cell wall composition, after
interaction with cell wall perturbing agents or disruption of
genes involved in wall biosynthesis (Dichtl et al., 2016). In
C. albicans, when mannan assembly is disrupted, the activation
of this pathway leads to increased levels of both chitin and β-
glucan (Bates et al., 2006, 2013; Mora-Montes et al., 2007, 2009,
2010). In the experimental conditions of deglycosylation, cells
are not suspended in culturing medium, and only rely on the
internal storages of nutrients and energy; therefore, it is possible
to suggest that C. guilliermondii is incapable to perform a full
wall adaptation to the deglycosylation process, implying that the
energy cost of glucan synthesis is lower than chitin elaboration.
Alternatively, it is also possible that the components of the cell
wall integrity pathway in C. guilliermondii are not the same, or
perform different functions, and the removal of mannan does
not lead to an increment in chitin levels. Nevertheless, further
studies are required to elucidate the components of this signaling
pathway in C. guilliermondii.
The analysis of the interaction of C. guilliermondii with
macrophages showed that the pmr11 null mutant was lesser
internalized than control strains, suggesting a key role for
mannans during the uptake by these phagocytic cells. In line, a
similar observation was reported in C. albicans, where lack of
cell wall mannans negatively affected uptake and phagocytosis
(McKenzie et al., 2010). Interestingly, we observed more death
macrophages after 24 h interaction with the null mutant cells
when compared to the control strains. This may be attributable to
the cell morphology of the mutant, as cell aggregates are likely to
damage macrophage membranes than single cells. Alternatively,
it is possible to suggest that the cell wall rearrangements could
expose molecules with toxic effects on the phagocytic cells.
The C. guilliermondii pmr11 null mutant had significantly
decreased virulence in both G. mellonella and murine models
of systemic candidiasis, similar to that reported for C. albicans
(Bates et al., 2005). However, in themouse model the re-integrant
strain failed to colonize and kill as the parental control cells,
recuperating similar CFU from organs to those obtained from
animals infected with the null mutant strain. The backbone
vector used to generate the pmr11 + PMR1 re-integrant strain
did not integrate into the C. guilliermondii genome, as it contains
an autonomously replicating sequence (Foureau et al., 2013a), so
it is tempting to speculate that cells growing in a rich nutrient
condition such as that which is present in the mouse milieu tend
to lose the plasmid containing PMR1. Indeed, when this strain
was grown in rich medium, like YPD or Sabouraud, the cells
tended to show phenotypic traits of the null mutant strain (data
not shown). Therefore, as previously demonstrated (Defosse
et al., 2014), growth on minimal medium is required to force
this strain to keep the plasmid that restores PMR1 mutation.
Nevertheless, our results clearly show virulence attenuation in the
mouse model upon PMR1 disruption.
In conclusion, we report that PMR1 regulates protein
mannosylation in C. guilliermondii and the affected
mannosylation processes are relevant during interaction
with the host. Loss of PMR1 in C. guilliermondii leads to
morphological alterations, defects in the ability to form biofilms,
and aberrant wall composition and organization. Furthermore,
N-linked and O-linked mannans have differential roles during
cytokine stimulation when C. guilliermondii cells interact with
innate immune cells. Finally, our results demonstrate that C.
guilliermondii, although is closely related to C. albicans, has
subtle but key differences in its biology, which makes it an
important model to study at both molecular and immunological
levels.
EXPERIMENTAL PROCEDURES
Strains and Growth Conditions
Organisms generated and used in this study are listed in
Table 2. Unless otherwise indicated, cells were maintained and
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TABLE 2 | Strains used in this work.
Strain Organism Origin Genotype References
ATCC 6260 C. guilliermondii ATCC Wild type ATCC
KU141 C. guilliermondii NP566U ura5, ku70::REP-URA5-REP Foureau et al., 2013b
KU141F1 C. guilliermondii Derived from KU141 ura5, ku70::REP Foureau et al., 2013b
HMY134 C. guilliermondii Derived from KU141F1 ura5, ku70::REP, pmr11::REP-URA5-REP This work
HMY136 C. guilliermondii Derived from HMY134 ura5, ku70::REP, pmr11::REP This work
HMY138 C. guilliermondii Derived from HMY136 ura5, ku70::REP, pmr11::REP + pGURA5-PMR1-YFP This work
HMY188 C. guilliermondii Derived from HMY136 ura5, ku70::REP, pmr11::REP + pGURA5-YFP-PMR1 This work
NGY152 C. albicans Derived from CAI-4 ura31-iro11::imm434/ ura31-iro11::imm434; RPSI/rps11::Clp10 Brand et al., 2004
NGY98 C. albicans Derived from NGY97 ura31-iro11::imm434/ ura31-iro11::imm434; pmr11::hisG/pmr11::hisG Bates et al., 2005
NGY355 C. albicans Derived from NGY98 As NGY98, but RPSI/rps11::Clp10 Bates et al., 2005
HMY186 C. albicans Derived from NGY98 As NGY205, but RPSI/rps11::Clp10-CgPMR1 This work
propagated at 30◦C in SC medium [0.76% (w/v) yeast nitrogen
base without amino acids, 2% (w/v) glucose] supplemented with
50 µg/mL uridine when required. To prepare cells for cytokine
assays and cell wall analysis, the strains were grown at 30◦C in 500
mL flasks containing 100mL of freshmediumwith shaking at 200
rpm until reaching mid-log phase of growth. Cells were HK by
incubating at 56◦C for 60min. Loss of cell viability was confirmed
by an absence of growth on SC plates after 48 h incubation
at 28◦C. For β-elimination assays, cell samples were treated as
previously described (Díaz-Jiménez et al., 2012). Briefly, cells
were suspended in 10 ml of NaOH 0.1 N and incubated at
room temperature during 18 h with gently shaking. The reaction
was stopped by neutralizing with HCl 0.1 N, and cells were
pelleted at 2000 × g, for 5 min. The supernatant was saved for
O-linked mannans analysis (see below). The N-linked mannan
removal was achieved by incubating at 37◦C with 25 U endo H
(New England Biolabs) as reported (Mora-Montes et al., 2012).
In both cases, cells were washed twice with sterile phosphate
buffered saline (PBS) and viability was demonstrated by the lack
of significant differences in the number of cfu/mL before and
after the treatment (loss of cell viability upon β-elimination and
endo H treatment was 3.6 ± 1.9% and 5.6 ± 3.7%, respectively).
Cell aggregates were dispersed by the addition of 2 units/mL
chitinase (Sigma) to medium (Bates et al., 2006; Pérez-García
et al., 2016).
Construction of the Cgpmr11 Null Mutant,
and Re-integrant Control Strain
The C. guilliermondii pmr11 null mutant was constructed
as follows. Genomic DNA of C. guilliermondii ATCC 6260
reference strain was first extracted and purified using Plant
Nucleospin II kit (Macherey-Nagel). This genomic DNA was
used to amplify by PCR a 2769 bp fragment (primers PMR11
5′-CTGAGAGGATCCATGACAGAGAACCCGTTCGATGTG-
3′ and PMR12 5′-CTGAGAACTAGTTACGCTGTAGCTGACT
CCATTCAT-3′) overlapping the CgPMR1 coding sequence.
PCR reactions were performed with Phusion DNA polymerase
(New England Biolabs). This PCR fragment was cloned into
pGEM-T easy vector (Promega) to yield pG-CgPMR1. To obtain
plasmid pG-5′PMR1-REP-URA5-REP-3′PMR1, pG-CgPMR1
was digested with BstBI to delete a 1115 bp central fragment in
the PMR1 coding sequence. The resulting digested plasmid was
ligated to the REP-URA5-REP fragment released after digestion
of the pG-REP-URA5-REP plasmid (Foureau et al., 2013b) with
ClaI (compatible with BstBI). The 5′PMR1-REP-URA5-REP-
3′PMR1disruption cassette was released from pGEM-T vector
after digestion of the pG-5′PMR1-REP-URA5-REP-3′PMR1with
NotI and used to transform the non-homologous end-joining
pathway deficient strain KU141F1 (genotype ura5, ku70)
(Foureau et al., 2013b). Transformation of C. guilliermondii
cells was performed as described previously (Millerioux et al.,
2011a). Ura+ transformants were selected on SC medium
after 4 days of growth at 35◦C. Genomic DNA of a series
of randomly selected Ura+ transformants was extracted and
homologous integration of the disruption cassette at the PMR1
locus was confirmed by PCR (Figure 2B). A representative null
mutant abbreviated pmr11 was chosen for further phenotype
analysis.
The pmr11 + PMR1 re-integrant strain was constructed
as follows. The codon-optimized sequence of YFP gene was
amplified with primers GYCN1 5′-CTGAGAGCTAGCATGT
CTAAAGGTGAAGAATTAT-3′ and GYCS2 5′-CTGAGAGT
CGACTTTGTACAATTCATCCATACCA-3′ using pYFP-URA3
(Gerami-Nejad et al., 2001)(kindly provided by C.A. Gale,
Department of Pediatrics, University of Minnesota, Minneapolis,
USA) as template, digested with NheI and SalI and cloned
into the corresponding site of the C. guilliermondii expression
vector pG-URA5-PACT1-TTRP1 (Defosse et al., 2014) between
the C. guilliermondii ACT1 promoter (PACT1) and the C.
guilliermondii phosphoribosylanthranilate isomerase (TRP1)
gene terminator (TTRP1) to yield pG-URA5-YFP. The 2769
bp PCR-amplified fragment (primers PMR11 and PMR12)
overlapping the PMR1 coding sequence was digested with BamHI
and SpeI and cloned into BamHI and NheI (compatible with
SpeI) of pG-URA5-YFP, in frame of the YFP gene, to yield
pG-URA5-PMR1-YFP. The 2769 bp PCR-amplified fragment
digested with BamHI and SpeI was also cloned into BglII
and AvrII (compatible with BamHI and SpeI, respectively) of
pG-URA5-YFP to yield pG-URA5-YFP-PMR1. A representative
pmr11 null mutant was subjected to a FOA counter-selection
Frontiers in Microbiology | www.frontiersin.org 14 December 2016 | Volume 7 | Article 1951
Navarro-Arias et al. Disruption of Candida guilliermondii PMR1
to select Ura− cells derived from URA5 marker loss (Millerioux
et al., 2011b). Genomic DNA of a series of randomly selected
Ura− FOA resistant clones was extracted and the loss of a
REP-URA5 fragment at the pmr1::REP-URA5-REP disrupted
locus was confirmed by PCR. A representative Ura− null
mutant strain (genotype pmr1::REP) was finally transformedwith
circular pG-URA5-PMR1-YFP or pG-URA5-YFP-PMR1. Ura+
transformants were selected on SC medium after 4 days of
growth at 35◦C. An Olympus BX51 epifluorescence microscope
equipped with the Olympus DP71 digital camera and the
Cell∗D imaging software (Soft Imaging System, Olympus) was
used for image capture and for merging false-colored images
of C. guilliermondii colonies expressing the YFP. Details on
the combinations of filters sets used for each application are
previously described (Courdavault et al., 2011).
Heterologous Complementation in
C. albicans
The CgPMR1 open reading frame, along with 1 Kbp
upstream and 600 bp downstream sequences (4307 bp
in total) was amplified by PCR using the primer pair
5′- GCGGCCGCGTTCGTGCGACTTTGGA-3′ and 5′-
GCGGCCGCGATCATAGGAACATGATGGG-3′ (sequences to
generate NotI sites are underlined). The amplicon was cloned
into pCR R©2.1-TOPO R© (Invitrogen), and subcloned into the
NotI site of CIp10 (Murad et al., 2000). Upon digestion with StuI
this construction was used for transformation of a Capmr11 null
mutant (Bates et al., 2005).
Analysis of Biofilm Formation
Biofilm formation and its analysis were performed as described
(Peeters et al., 2008). Briefly, 100 µL aliquots containing 1 × 106
cells were seeded in flat-bottom polystyrene 96-microtiter plates
(NUNC) and allowed to adhere for 4 h at 30◦C. Non-adherent
cells were removed and wells were rinsed using 100 µL PBS.
Then, 100 µL of fresh SC medium were added to each well and
the plate was incubated 24 h at 30◦C. The medium was discarded,
wells were thoroughly rinsed with PBS and cells were fixed with
100 µL of 99% (v/v) methanol. After 15min incubation at room
temperature, the methanol was removed and plates were allowed
to air-dry. Aliquots containing 100 µL of 0.02% (w/v) crystal
violet were then added to each well and 20min later plates were
rinsed with water. Finally, the reaction was developed by the
addition of 150 µL of 33% (v/v) acetic acid and the absorbance
was measured at 590 nm. Values generated with the WT strain
were considered as 100% and used for data normalization.
Analysis of Cell Wall Composition
Cells were mechanically broken in a Braun homogenizer during
5 min and under a CO2 stream; with cycles of 1 min, with 2-
min resting periods on ice. The homogenate was centrifuged
and cell walls were recovered, extensively washed with deionized
water, cleansed and acid-hydrolyzed as described (Mora-Montes
et al., 2007). Acid-hydrolyzed samples were analyzed by HPAEC-
PAD in a carbohydrate analyzer system from Dionex, using the
separation conditions previously reported (Cheng et al., 2011;
Pérez-García et al., 2016).
Cell wall protein content was determined upon wall hydrolysis
in alkali (Mora-Montes et al., 2007), using the Bradford protein
assay.
Cell wall porosity was assessed by relative porosity to
polycations as reported (DeNobel et al., 1990). Briefly, overnight-
grown cells were harvested by centrifuging and inoculated into
fresh SC broth, incubated for 8 h at 30◦C and 200 rpm, and
washed twice with PBS. Pellets containing 1 × 108 cells were
suspended in either 10 mM Tris-HCl, pH 7.4 (buffer A), buffer
A plus 30 µg/mL poly-L-lysine (MW 30–70 kDa, Sigma Cat.
No. P-2636) or buffer A plus 30 µg/mL DEAE-dextran (MW
500 kDa, Sigma Cat. No. D-9885), and incubated for 30 min
at 30◦C with constant shaking at 200 rpm. Cells were pelleted
by centrifugation, and the supernatants were collected and
measured at an absorbance of 260 nm. The relative cell wall
porosity to DEAE-dextran was calculated as described, using the
porosity to poly-L-lysine for data normalization (De Nobel et al.,
1990).
The content of cell wall phosphomannan was determined by
the ability of cells to bind Alcian blue. Cells in exponential growth
phase were collected, washed twice with deionized water and
adjusted to an OD600 of 0.2. Aliquots of 1 mL were pelleted and
cells suspended in 1 mL of 30µg/mL Alcian blue (in 0.02 MHCl)
and analyzed as described (Hobson et al., 2004).
Analysis of Cell Wall N-Linked and
O-Linked Mannan Content
Cells were incubated overnight at 37◦C with 25 U endo H (New
England Biolabs) to trim cell wall N-linked mannans (Mora-
Montes et al., 2012). Cells were also β-eliminated as described
(Díaz-Jiménez et al., 2012). In both cases, cells were centrifuged,
and the supernatant were freeze-dried and used to quantify the
sugar content according to a reported the phenol-sulfuric-acid
protocol (Dubois et al., 1956). In both cases, mannan release
was confirmed by HPAEC-PAD as described (Pérez-García et al.,
2016).
Fluorophore-Assisted Carbohydrate
Electrophoresis
Aliquots containing 20mg O-linked mannans were derivatized
with 8-aminonaphthalene-1,3,6-trisulfonic acid and sodium
cyanoborohydride for at least 16 h at 37◦C, as previously
described (Jackson, 1990). The material was then dried under
vacuum and separated in a 35% (w/v) polyacrylamide gel under
non-denaturing conditions, for 6 h at 4◦C and 200 V. The gel
was inspected under UV light, and the image was captured
using the Chemidoc MP system (Bio-Rad). As control, a sample
from C. albicans NGY152 O-linked mannans was analyzed
under the same conditions. The molecular marker used was a
ladder of maltooligosaccharides from one to seven glucose units
(Sigma).
Fluorochrome Staining
Chitin staining was performed as described (Mora-Montes et al.,
2011), using 1 mg/mLWGA-FITC (Sigma). The labeling of β1,3-
glucan was performed with 5 µg/mL IgG Fc-Dectin-1 chimera
(Graham et al., 2006) for 40 min at room temperature, followed
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by incubation with 1 µg/mL donkey anti Fc IgG-FITC for
40 min at room temperature (Marakalala et al., 2013). The
samples were examined by fluorescence microscopy using a Zeiss
Axioscope-40 microscope and an Axiocam MRc camera. From
the pictures acquired, the fluorescence quantification of 100 cells
was achieved using Adobe PhotoshopTM CS6 using the formula:
[(total of green pixels-background green pixels) × 100]/total
pixels. The experiment was performed three independent times,
with a total of 300 cells analyzed per strain.
Susceptibility to Cell Wall Perturbing
Agents and Antifungal Drugs
Strains were assessed for susceptibility to wall perturbing agents
using the described microdilution method (Bates et al., 2005).
Cells were cultivated overnight in SC medium supplemented
with 2 units/mL chitinase and then collected and washed with
deionized water. The cells were separated using a syringe with
a 32-gauge needle, and suspended to an OD600 = 1. Then, cells
were inoculated into fresh SC medium at an OD600 of 0.01 and
95 µL were distributed into the wells of 96-well plates. The
cell wall perturbing agents, in a final volume of 5 µL, were
added to each well. Control wells received 5 µL of vehicle only
and were used to normalize the results. The final OD600 for
each well was determined after 24 h incubation at 30◦C. The
maximum concentrations tested for each agent were: 400 µg/mL
CalcofluorWhite (CFW, Sigma), 200µg/mLCongo Red (Sigma),
300 µg/mL hygromycin B (GoldBio); 50 µg/mL tunicamycin
(Sigma) and 0.1% (w/v) SDS (Invitrogen). Growth data were
normalized as percentage of those generated with the same strain
with no treatment (medium only).
The minimum inhibitory concentration of the antifungal
agents was performed according to the CLSI document M27-
S4. Samples of 100 µL with 1 × 103 cells from overnight
cultures were seeded in round-bottom 96-well plates containing
serial dilutions of the tested drugs in RPMI 1640 (Gibco). The
initial drug concentration for fluconazole and nystatin were 125
µg/mL and 16 µg/mL, respectively. Plates were incubated at
35◦C for 24 h before the minimum inhibitory concentration was
determined.
Ethics Statement
The use of human primary cells was approved by the Ethics
Committee from Universidad de Guanajuato (permission
number 17082011). The primary cells were collected from
healthy adult volunteers. The Ethics Committee at the
University of Szeged approved the experimentation with
mice (XII./00455/2011).
Isolation and Stimulation of Human PBMCs
with C. guilliermondii Cells
Human PBMCs were isolated using Histopaque-1077 (Sigma) as
reported (Endres et al., 1988). To stimulate cytokine production,
100 µL containing 5 × 105 PBMCs in RPMI 1640 Dutch
modification (added with 2 mM glutamine, 0.1 mM pyruvate and
0.05 mg/mL gentamycin; all reagents from Sigma) were plated
onto round-bottom 96-well microplates, and 100µLwith 1× 105
fungal cells freshly harvested or treated were added to each well.
The co-cultures were incubated for 24 h at 37◦C with 5% (v/v)
CO2. In some experiments, PBMCs were pre-incubated for 1 h
at 37◦C with 200 µg/mL laminarin before stimulation with yeast
cells. Laminarin used for the pre-incubation experiments was not
contaminated with LPS (tested with the Limulus amebocyte lysate
from Sigma); however, all reactions were performed in presence
of 5 µg/mL polymyxin B (Sigma) (Schwartz et al., 1972). The
plates were centrifuged for 10min at 3000 × g at 4◦C, and the
supernatants were collected and stored at−20◦C until used.
Cytokine Quantification
The concentrations of TNFα, IL-6, and IL-10 were quantified by
ELISAs (Peprotech), and IL-1β levels were determined using an
ELISA kit from R&D Systems.
Macrophage Infection with Yeasts
Macrophages from the J774 cell line were infected as described
(Dementhon et al., 2012) in cRPMI medium (RPMI-1640 from
Sigma without phenol red and supplemented with 10% heat-
inactivated FBS, 1 mM sodium pyruvate and 2 g/L sodium
bicarbonate) at 37◦C under 5% (v/v) CO2. A Multiplicity of
Infection (MOI) of 1 macrophage to 1 yeast (1M:1Y) was
used for all experiments, except for yeast viability, which we
used 10M:1Y. Macrophages (2 × 105 per well) were adhered
overnight in 96-well plates and then CFW-labeled yeast cells
were added in cRPMI in the presence of 5 µg/mL CFW to allow
the continuous labeling of newly replicated yeasts outside the
macrophages.
Fluorimetry and Flow Cytometry Assays
Fluorimetry and flow cytometry assays were conducted as
previously described (Dementhon et al., 2012). Fluorimetry was
used to determine the multiplication of the fungal biomass and
the ratio of ingested fungal cells after 1, 5, and 24 h of infection.
Briefly, wemeasured the total fluorescence of CFW-labeled yeasts
per well. The fungal biomass multiplication was determined
by comparing the CFW fluorescence at 5 and 24 h with the
fluorescence of the initial biomass at 1 h. To determine the uptake
of fungal cells by the macrophages, a final concentration of
250 µg/mL trypan blue was used to quench the fluorescence
of extracellular CFW-labeled yeasts. The residual fluorescence
of internalized CFW-labeled yeasts was measured and expressed
as a percentage of the total fluorescence. Flow cytometry was
used to measure the macrophage and yeast mortality rates,
and the ratio of macrophages engaged in phagocytosis. Briefly,
macrophages were double-stained with anti-mouse CD16-APC
(a membrane stain, from BioLegend) and calcein-AM (a marker
of active metabolism, from Sigma) at 1, 5, and 24 h of incubation
with CFW-labeled yeasts. The percentage of macrophage viability
was calculated as the number of macrophages positive for
both fluorescence (calcein-AM and anti-CD16) in an infection
assay compared to wells with uninfected macrophages (control).
Phagocytosing macrophages were quantified as the number
of macrophages positive for calcein, anti-CD16 and CFW
fluorescence.
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G. mellonella Survival Assays
Infection and killing assays of waxmoth larvae were conducted as
reported (Pérez-García et al., 2016). Briefly, aliquots containing 2
× 107 yeast cells in 10 µL PBS were passaged through a syringe
with a 32-gauge needle, and injected directly into the hemocoel,
through the last left pro-leg of the larva, using a Hamilton syringe
and a 26-gauge needle. Larvae were maintained at 25◦C after
injection and survival was monitored daily. Each experimental
group contained 10 larvae. PBS-injected and untreated larvae
were included in each experiment as controls.
C. guilliermondii Infection Model and
Fungal Burden
Anon-lethal experimental model of disseminated candidiasis was
performed as reported (Ifrim et al., 2014; Pérez-García et al.,
2016). Animal groups containing five 8- to 12-weeks-old male
Balb/c WT mice (22–27 g of weight) were injected via the lateral
tail vein with 2 × 107 C. guilliermondii yeast cells, previously
passaged through a syringe with a 32-gauge needle, in 100 µL
of sterile PBS. As a control group, 5 mice were injected with
100 µL of sterile PBS. Animals were mantained with sterile
water and normal diet ad libitum. Mice were monitored daily
and they showed no signs of disease like weight loss, lethargy,
ruﬄed fur or rapid shallow breathing during 5 days following
intravenous infection. After 2 or 5 days post infection, animals
were humanitarianly euthanatized, and the liver, kidneys and
spleen were removed, weighed, and separately homogenized
with a tissue grinder. The tissue fungal burden was quantified
by plating serial dilutions on YPD agar plates. The CFU were
counted after 48 h of incubation at 30◦C and expressed as CFU/g
tissue.
Statistical Analysis
Statistical analysis was performed using GraphPad Prism 6
software. Growth data in the presence of cell wall perturbing
agents were analyzed by two-way ANOVA. Cytokine stimulation
using human PMBCs was performed in duplicate with six
healthy donors, whereas the rest of the in vitro experiments were
performed at least thrice in duplicate. Data represent cumulative
results of all experiments performed. The Mann-Whitney U test
or unpaired t-test was used to establish statistical significance (see
figure legends for details), with a significance level set at P< 0.05.
Experiments withG. mellonellawere performed three times, with
a total of 30 larvae per group (10 larvae for each experiment).
Results were analyzed using the Log-rank test and arranged
in survival curves using Kaplan-Meier charts. The statistical
significance was set at P < 0.05.
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